| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |